InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by Kelly Thomas Patrick, Chief Financial Officer. Director active across 1 company, notably Deciphera Pharmaceuticals, Inc.. Cumulatively, 7 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €40k. Activity tracked since 15 December 2021. The latest transaction was filed on 16 June 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
1,768 shares@ US$10.7545.3% of flowCommon StockSEC:0001209191-22-038426:0
1,368 shares@ US$9.0527.4% of flowCommon StockSEC:0001209191-22-011357:0
1,368 shares@ US$9.05100.0% of flowCommon StockSEC:0001209191-22-011357
20,500 shares0Common StockSEC:0001209191-22-004078:0
20,500 shares0Common StockSEC:0001209191-22-004078
11,100 shares0Common StockSEC:0001209191-21-070250
11,100 shares0Common StockSEC:0001209191-21-070250:0
7 of 7 declarations
About Kelly Thomas Patrick
Kelly Thomas Patrick is the Chief Financial Officer of Deciphera Pharmaceuticals, Inc. In this role, he is responsible for managing the company's finances, including financial planning, risk management, and investment strategy. His role is crucial in ensuring the financial health of the organization and supporting its growth. Kelly Thomas Patrick works closely with other executives to align financial objectives with the overall strategy of the company.
